Human skeletal muscle cells with a slow adhesion rate after isolation and an enhanced stress resistance improve function of ischemic hearts.

[1]  J. Vella,et al.  Cellular antioxidant levels influence muscle stem cell therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  S. Nyberg,et al.  E-Cadherin Protects Primary Hepatocyte Spheroids from Cell Death by a Caspase-Independent Mechanism , 2009, Cell transplantation.

[3]  R. Gomer,et al.  Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts , 2009, PloS one.

[4]  G. Butler-Browne,et al.  In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  P. Menasché,et al.  Does the human skeletal muscle harbor the murine equivalents of cardiac precursor cells? , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[7]  E. Andreu,et al.  Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.

[8]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[9]  A. Uezumi,et al.  Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. , 2008, The American journal of pathology.

[10]  B. Zheng,et al.  Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique , 2008, Nature Protocols.

[11]  T. Yau,et al.  Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. , 2008, Seminars in thoracic and cardiovascular surgery.

[12]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[13]  P. Tonali,et al.  Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle Biopsies , 2007, Stem cells.

[14]  K. Tobita,et al.  A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. , 2007, Journal of the American College of Cardiology.

[15]  B. Zheng,et al.  Prospective identification of myogenic endothelial cells in human skeletal muscle , 2007, Nature Biotechnology.

[16]  C. Lau,et al.  Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium , 2007, European journal of heart failure.

[17]  M. Rudnicki,et al.  Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  Shuhua Yang,et al.  Role of caspase-3 inhibitor in induced anoikis of mesenchymal stem cells in vitro , 2007, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[19]  B. Sacchetti,et al.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells , 2007, Nature Cell Biology.

[20]  Ying Zhang,et al.  Cellular Cardiomyoplasty: Improvement of Left Ventricular Function Correlates with the Release of Cardioactive Cytokines , 2007, Stem cells.

[21]  R. Sarig,et al.  Regeneration and Transdifferentiation Potential of Muscle‐Derived Stem Cells Propagated as Myospheres , 2006, Stem cells.

[22]  Johnny Huard,et al.  Differential myocardial infarct repair with muscle stem cells compared to myoblasts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  S. Mohan,et al.  Pregnancy-associated Plasma Protein-A Regulates Myoblast Proliferation and Differentiation through an Insulin-like Growth Factor-dependent Mechanism* , 2005, Journal of Biological Chemistry.

[24]  J. Huard,et al.  Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells , 2005, Gene Therapy.

[25]  M. Rubart,et al.  Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. , 2004, The Journal of clinical investigation.

[26]  M. Yacoub,et al.  Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  C. Murry,et al.  Evidence for Fusion Between Cardiac and Skeletal Muscle Cells , 2004, Circulation research.

[28]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[29]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[30]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[31]  P. Menasché.  Cellular transplantation: hurdles remaining before widespread clinical use , 2004, Current opinion in cardiology.

[32]  E. Audinat,et al.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Murry,et al.  Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. , 2002, Journal of molecular and cellular cardiology.

[34]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[35]  C. Murry,et al.  Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. , 2000 .

[36]  T. Partridge,et al.  Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell–like Properties as the Myogenic Source , 1999, The Journal of cell biology.

[37]  Johnny Huard,et al.  Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy , 1998, The Journal of cell biology.

[38]  G. Acsadi,et al.  Gene transfer into skeletal muscles by isogenic myoblasts. , 1994, Human gene therapy.

[39]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[40]  J. Vella,et al.  Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. , 2009, Molecular biology of the cell.

[41]  岡田 正穂.  Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium , 2009 .